News
EMA gives green light to avapritinib for GIST, acalabrutinib for CLL
The Committee for Medicinal Products for Human Use has given a favorable opinion on both drugs.
News
Survey: U.S. oncologists have high net worth, live within their means
Among U.S. oncologists surveyed, the average annual income was $377,000.
News
Geographical hot spots for early-onset colon cancer
Possible explanations for the increased incidence in these areas “include an enduring history of unique challenges, such as inadequate access to...
News
Pembro approved for first-line use in MSI-H/dMMR colorectal cancer
This is the first time an immunotherapy has been approved in this setting and as monotherapy.
News
‘Hospital at home’ cuts ED visits and costs for cancer patients
An oncology hospital-at-home model was associated with a reduction in hospitalizations, emergency department visits, and costs.
News
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
